{
    "clinical_study": {
        "@rank": "163392", 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare and evaluate the safety of AVP-923\n      (dextromethorphan/quinidine) for the treatment of emotional lability in ALS patients."
        }, 
        "brief_title": "Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS", 
        "completion_date": "March 2002", 
        "condition": "Amyotrophic Lateral Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Sclerosis", 
                "Motor Neuron Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion:\n\n          -  18 to 80 years of age, inclusive\n\n          -  Confirmed diagnosis of ALS or probable ALS\n\n          -  Clinical history of pseudobulbar affect\n\n          -  If female, must not be pregnant, breast-feeding, or planning a pregnancy during the\n             course of the study, and must have a negative urine pregnancy test prior to start of\n             study\n\n          -  If female, must have been practicing an established method of birth control for at\n             least the prior month (oral contraceptive tablets, hormonal implant device,\n             intrauterine device, diaphragm and contraceptive cream or foam, condom with\n             spermicide, tubal ligation, or abstinence) or be surgically sterile or\n             post-menopausal\n\n          -  Must be willing to not take any prohibited medications during participation in the\n             study\n\n        Exclusion:\n\n          -  Known sensitivity to quinidine or opiate drugs (codeine, etc.)\n\n          -  On any anti-depressive medication\n\n          -  Recently (within two months) diagnosed with ALS\n\n          -  Currently participating in, or who within the past 30 days have participated in, the\n             study of another investigational new drug\n\n          -  Previously received treatment with co-administration of dextromethorphan and\n             quinidine\n\n          -  History of substance abuse within the past two years\n\n          -  Women who are pregnant or likely to become pregnant during the course of the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "100", 
        "firstreceived_date": "August 1, 2001", 
        "id_info": {
            "nct_id": "NCT00021697", 
            "org_study_id": "99-AVR-102", 
            "secondary_id": "AVP-923"
        }, 
        "intervention": {
            "intervention_name": "AVP-923", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Dextromethorphan", 
                "Quinidine"
            ]
        }, 
        "keyword": [
            "AVP-923", 
            "Dextromethorphan", 
            "Quinidine", 
            "Pseudobulbar Affect"
        ], 
        "lastchanged_date": "April 10, 2014", 
        "link": [
            {
                "description": "Sponsor's website", 
                "url": "http://www.avanir.com"
            }, 
            {
                "description": "Homepage for ALSA/ALS", 
                "url": "http://www.alsa.org"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Loma Linda", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92354"
                    }, 
                    "name": "Loma Linda University Dept. of Neurology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA School of Medicine Dept. of Neurology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143"
                    }, 
                    "name": "University of California, San Francisco"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80262"
                    }, 
                    "name": "University of Colorado Health Sciences"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "University of Miami Dept. of Neurology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern Medical School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }, 
                    "name": "Johns Hopkins University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia-Presbyterian Center Neurological Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13210"
                    }, 
                    "name": "State University of New York"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28203"
                    }, 
                    "name": "Carolinas Medical Center Carolinas Neuromuscular/ALS-MDA Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27157"
                    }, 
                    "name": "Wake Forest University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }, 
                    "name": "Cleveland Clinic Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "MCP-Hahnemann University Dept. of Neurology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Penn Neurological Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "University of Texas Health Science Center @ San Antonio"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53792"
                    }, 
                    "name": "University of Wisconsin ALS Clinical Research Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Double-Blind Controlled, Multicenter Phase II/III Study to Assess the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect in Patients With Amyotrophic Lateral Sclerosis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "reference": [
            {
                "PMID": "8887697", 
                "citation": "Dark FL, McGrath JJ, Ron MA. Pathological laughing and crying. Aust N Z J Psychiatry. 1996 Aug;30(4):472-9. Review."
            }, 
            {
                "citation": "Smith RA, Moore SR, Gresham LS, Manley PE, Licht JM: The treatment of affective lability with dextromethorphan. Neurology 54: 604P, 1995"
            }, 
            {
                "PMID": "2816272", 
                "citation": "Gallagher JP. Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand. 1989 Aug;80(2):114-7."
            }, 
            {
                "PMID": "573397", 
                "citation": "Wolf JK, Santana HB, Thorpy M. Treatment of \"emotional incontinence\" with levodopa. Neurology. 1979 Oct;29(10):1435-6. No abstract available."
            }, 
            {
                "PMID": "10576464", 
                "citation": "Muller U, Murai T, Bauer-Wittmund T, von Cramon DY. Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Inj. 1999 Oct;13(10):805-11."
            }, 
            {
                "PMID": "9221973", 
                "citation": "Moore SR, Gresham LS, Bromberg MB, Kasarkis EJ, Smith RA. A self report measure of affective lability. J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):89-93."
            }, 
            {
                "PMID": "7593709", 
                "citation": "Schadel M, Wu D, Otton SV, Kalow W, Sellers EM. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol. 1995 Aug;15(4):263-9."
            }, 
            {
                "PMID": "23991068", 
                "citation": "Brooks BR, Crumpacker D, Fellus J, Kantor D, Kaye RE. PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS One. 2013 Aug 21;8(8):e72232. doi: 10.1371/journal.pone.0072232. eCollection 2013."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00021697"
        }, 
        "results_reference": {
            "PMID": "15505150", 
            "citation": "Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, Pope LE, Smith RA; AVP-923 ALS Study Group. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004 Oct 26;63(8):1364-70."
        }, 
        "source": "Avanir Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Avanir Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }, 
    "geocoordinates": {
        "Carolinas Medical Center Carolinas Neuromuscular/ALS-MDA Center": "35.227 -80.843", 
        "Cleveland Clinic Foundation": "41.499 -81.695", 
        "Columbia-Presbyterian Center Neurological Institute": "40.714 -74.006", 
        "Johns Hopkins University": "39.29 -76.612", 
        "Loma Linda University Dept. of Neurology": "34.048 -117.261", 
        "MCP-Hahnemann University Dept. of Neurology": "39.952 -75.164", 
        "Massachusetts General Hospital": "42.358 -71.06", 
        "Northwestern Medical School": "41.878 -87.63", 
        "Penn Neurological Institute": "39.952 -75.164", 
        "State University of New York": "43.048 -76.147", 
        "UCLA School of Medicine Dept. of Neurology": "34.052 -118.244", 
        "University of California, San Francisco": "37.775 -122.419", 
        "University of Colorado Health Sciences": "39.739 -104.985", 
        "University of Miami Dept. of Neurology": "25.789 -80.226", 
        "University of Texas Health Science Center @ San Antonio": "29.424 -98.494", 
        "University of Wisconsin ALS Clinical Research Center": "43.073 -89.401", 
        "Wake Forest University": "36.1 -80.244"
    }
}